Consulting

Many clients may need CMC guidance prior to committing to a full development project. Scienico Healthcare has extensive therapeutic area expertise and can advise on designing an effective development path to take your compound to clinic. Whether it is converting an oral molecule to topical administration, re-purposing a known molecule, or simply changing the vehicle or dosage form, we can help. Scienico Healthcare has alliances and working relationships with many CROs for IND-exploratory toxicology studies that can speed up the process.

Scienico Healthcare can help identify various CMC gaps for your in-licensing/out-licensing portfolios or platform technologies.

Financial and infrastructure resource constraints are a reality of pharmaceutical development, driving companies to re-examine every asset and portfolio. With our experience, we can help you navigate global regulatory pathways, streamline your development program to fit your budget, and make more informed decisions faster.